Express Pharma

Biocon appoints Suresh Subramanian as Head of Branded Formulations (India) Business


Over 30 years of experience in the pharma market, he has worked with MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer

Biocon has announced the appointment of Suresh Subramanian as Senior Vice President & Head of the company’s branded formulations (India) business.

Subramanian has over 30 years of experience in the pharma market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer. Over the years, he has played multiple leadership roles in business development, marketing, sales and strategy. He has experience in multiple product launches, business optimisation, cost control, talent development and performance management.

Subramanian has managed a wide portfolio spanning diverse therapy areas such as neurosciences, respiratory, cardiology, oncology, critical care, gastro-intestinal, ophthalmology, pain & inflammation and women’s health in the Indian market. He has also been a part of the Steering Committee for McKinsey’s India Pharma 2020 report.

Kiran Mazumdar-Shaw, CMD, Biocon said, “We are extremely delighted to have Suresh Subramanian lead our Branded Formulations business in India. Suresh has deep expertise in diverse therapy areas including oncology, cardiology and critical care and has a proven track record of delivering robust business growth. We are sure, under his leadership, our branded formulations business will evolve further and become a strong value builder for Biocon.”

Suresh Subramanian is a Physics graduate and has a Masters degree in Marketing Management from Mumbai University.

EP News Bureau

Comments are closed.